Literature DB >> 11309443

Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma.

K Pacak, T Fojo, D S Goldstein, G Eisenhofer, M M Walther, W M Linehan, L Bachenheimer, J Abraham, B J Wood.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11309443      PMCID： PMC2386878          DOI： 10.1093/jnci/93.8.648

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

1.  Percutaneous radiofrequency ablation of malignancies in the lung.

Authors:  D E Dupuy; R J Zagoria; W Akerley; W W Mayo-Smith; P V Kavanagh; H Safran
Journal:  AJR Am J Roentgenol       Date:  2000-01       Impact factor: 3.959

2.  Percutaneous radiofrequency (RF) ablation therapy for hepatocellular carcinoma: difficulty in removing the expandable RF needle electrode.

Authors:  T Seki; T Tamai; T Nakagawa; K Inoue
Journal:  AJR Am J Roentgenol       Date:  2000-01       Impact factor: 3.959

3.  Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer.

Authors:  A R Zlotta; B Djavan; C Matos; J C Noel; M O Peny; D E Silverman; M Marberger; C C Schulman
Journal:  Br J Urol       Date:  1998-02

4.  Radiofrequency ablation of breast cancer: first report of an emerging technology.

Authors:  S S Jeffrey; R L Birdwell; D M Ikeda; B L Daniel; K W Nowels; F M Dirbas; S M Griffey
Journal:  Arch Surg       Date:  1999-10
  4 in total
  19 in total

Review 1.  Radiofrequency ablation beyond the liver.

Authors:  Ziv Neeman; Bradford J Wood
Journal:  Tech Vasc Interv Radiol       Date:  2002-09

Review 2.  Percutaneous ablation of adrenal tumors.

Authors:  Aradhana M Venkatesan; Julia Locklin; Damian E Dupuy; Bradford J Wood
Journal:  Tech Vasc Interv Radiol       Date:  2010-06

3.  Complications of radiofrequency ablation of neoplasms.

Authors:  Albert A Nemcek
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

Review 4.  Percutaneous tumor ablation with radiofrequency.

Authors:  Bradford J Wood; Jeffrey R Ramkaransingh; Tito Fojo; McClellan M Walther; Stephen K Libutti
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

Review 5.  Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.

Authors:  Victoria L Martucci; Karel Pacak
Journal:  Curr Probl Cancer       Date:  2014-01-15       Impact factor: 3.187

6.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

7.  Pheochromocytoma and paraganglioma.

Authors:  Vitaly Kantorovich; Karel Pacak
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

8.  The many faces of pheochromocytoma.

Authors:  H K Ghayee; K L Wyne; F S Yau; W H Snyder; S Holt; S Tunc Gokaslan; F Nwariaku
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

Review 9.  Radiofrequency ablation of cancer.

Authors:  Marc Friedman; Igor Mikityansky; Anthony Kam; Steven K Libutti; McClellan M Walther; Ziv Neeman; Julia K Locklin; Bradford J Wood
Journal:  Cardiovasc Intervent Radiol       Date:  2004-06-03       Impact factor: 2.740

10.  Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cells.

Authors:  Joel T Adler; Daniel G Hottinger; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.